Compare SLND & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLND | ASRT |
|---|---|---|
| Founded | 1900 | 1995 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.0M | 76.0M |
| IPO Year | N/A | 2004 |
| Metric | SLND | ASRT |
|---|---|---|
| Price | $1.07 | $22.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $18.00 |
| AVG Volume (30 Days) | 71.1K | ★ 409.3K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.59 | $12.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $0.60 |
| 52 Week High | $5.34 | $22.50 |
| Indicator | SLND | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | 87.22 |
| Support Level | $0.98 | $0.70 |
| Resistance Level | $1.80 | N/A |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.01 | 0.34 |
| Stochastic Oscillator | 45.43 | 99.78 |
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.